Prescription Drug Shortages: Impact on Neonatal Intensive Care.

MedStar author(s):
Citation: Neonatology. 115(2):108-115, 2018 Nov 01.PMID: 30384374Institution: MedStar Washington Hospital CenterDepartment: Emergency MedicineForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Drugs, Generic/sd [Supply & Distribution] | *Intensive Care Units, Neonatal/sn [Statistics & Numerical Data] | *Intensive Care, Neonatal/st [Standards] | *Prescription Drugs/sd [Supply & Distribution] | Humans | Infant, Newborn | Intensive Care Units, Neonatal/td [Trends] | Intensive Care, Neonatal/og [Organization & Administration] | Neonatologists | United StatesYear: 2018ISSN:
  • 1661-7800
Name of journal: NeonatologyAbstract: BACKGROUND: Prescription drug shortages have increased significantly during the past two decades and also impact drugs used in critical care and pediatrics.CONCLUSIONS: Drug shortages affected many agents used in NICUs, which can have quality and safety implications for patient care, especially in extremely low birth weight infants. Neonatologists must be aware of current shortages and implement mitigation strategies to optimize patient care.Copyright (c) 2018 S. Karger AG, Basel.METHODS: Drug shortage data for the top 100 NICU drugs were retrieved from the University of Utah Drug Information Service from 2001 to 2016. Data were analyzed focusing on drug class, formulation, reason for shortage, and shortage duration.OBJECTIVES: To analyze drug shortages affecting medications used in neonatal intensive care units (NICUs).RESULTS: Seventy-four of the top 100 NICU drugs were impacted by 227 shortages (10.3% of total shortages). Twenty-eight (12.3%) shortages were unresolved as of December 2016. Resolved shortages had a median duration of 8.8 months (interquartile range 3.6-21.3), and generic drugs were involved in 175 (87.9%). An alternative agent was available for 171 (85.8%) drugs but 120 (70.2%) of alternatives were also affected by shortages. Parenteral drugs were involved in 172 (86.4%) shortages, with longer durations than nonparenteral drugs (9.9 vs. 6.4 months, p = 0.022). The most common shortage reason was manufacturing problems (32.2%).All authors: Fox E, Mazer-Amirshahi M, Samiee-Zafarghandy S, van den Anker JN, Ziesenitz VC, Zocchi MFiscal year: FY2019Digital Object Identifier: Date added to catalog: 2018-11-09
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 30384374 Available 30384374

BACKGROUND: Prescription drug shortages have increased significantly during the past two decades and also impact drugs used in critical care and pediatrics.

CONCLUSIONS: Drug shortages affected many agents used in NICUs, which can have quality and safety implications for patient care, especially in extremely low birth weight infants. Neonatologists must be aware of current shortages and implement mitigation strategies to optimize patient care.

Copyright (c) 2018 S. Karger AG, Basel.

METHODS: Drug shortage data for the top 100 NICU drugs were retrieved from the University of Utah Drug Information Service from 2001 to 2016. Data were analyzed focusing on drug class, formulation, reason for shortage, and shortage duration.

OBJECTIVES: To analyze drug shortages affecting medications used in neonatal intensive care units (NICUs).

RESULTS: Seventy-four of the top 100 NICU drugs were impacted by 227 shortages (10.3% of total shortages). Twenty-eight (12.3%) shortages were unresolved as of December 2016. Resolved shortages had a median duration of 8.8 months (interquartile range 3.6-21.3), and generic drugs were involved in 175 (87.9%). An alternative agent was available for 171 (85.8%) drugs but 120 (70.2%) of alternatives were also affected by shortages. Parenteral drugs were involved in 172 (86.4%) shortages, with longer durations than nonparenteral drugs (9.9 vs. 6.4 months, p = 0.022). The most common shortage reason was manufacturing problems (32.2%).

English

Powered by Koha